ANTIGENO CARCINOEMBRIONARIO CANCER COLON PDF

Palabras clave: Marcadores Biológicos de Tumor. Cáncer. Diagnóstico. . en , alfa-fetoproteína (AFP) en , antígeno carcinoembrionario (CEA) en .. Otros tumores (biliares, gástricos, de colon, hígado, ovario, endometrio, . Antígeno carcinoembrionario. de algunas personas que tienen ciertos tipos de cáncer, especialmente cáncer del intestino grueso (cáncer de colon y recto). ASSOCIATION BETWEEN LEVELS OF CARCINOEMBRYONIC ANTIGEN (CEA) AND PROGNOSTIC VARIABLES OF COLON CANCER. Rev. Cir. Parag.

Author: Kelar Kazirn
Country: Uzbekistan
Language: English (Spanish)
Genre: Education
Published (Last): 18 December 2011
Pages: 410
PDF File Size: 7.85 Mb
ePub File Size: 16.20 Mb
ISBN: 751-8-60076-504-5
Downloads: 42958
Price: Free* [*Free Regsitration Required]
Uploader: Vutaur

Complejo Hospitalario y Universitario de Albacete. Unidad de Medicina Paliativa. La utilidad de los marcadores tumorales viene carcinoebmrionario por la sensibilidad y especificidad de cada uno de ellos.

Tumor markers are molecules usually glycoproteinsthe levels of which may be elevated in the presence of a cancer, either as a host’s reaction to the tumor or as a product of the tumor itself. These molecules, whose serum concentration also depends on the biological variability of the patient, are detectable in different biological fluids. The usefulness of tumor markers is determined by the sensitivity and specificity of each of them.

A tumor marker with a high sensitivity would be the one that is elevated in the majority of patients who present certain neoplasm, whereas specificity would be determined by those patients with normal levels of the tumor marker who do not present any type of neoplasm.

Thus, markers with high levels of sensitivity and specificity would allow for the detection of patients with cancer, and for their differentiation from healthy individuals or from patients with benign pathologies.

We can say that, in general, due to the lack of high diagnostic sensitivity and specificity, tumor markers are not helpful for an early detection of neoplasms, but they do help to confirm a diagnosis already established by more sensitive methods. Most markers also have a prognostic value at the time of diagnosis, since their concentration is related to tumor size. However, their true clinical value lies in patient monitoring, both for detecting early recurrence and for evaluating the effectiveness of the established treatment.

  ASSIMIL EL NUEVO ITALIANO SIN ESFUERZO PDF

Our aim is to review the tumor markers most commonly used in our clinical practice, as well as some agreed recommendations on the indication of their determination in various tumors.

El uso de los MT tiene algunas limitaciones: Por ello, el principal dato a tener en cnacer va a ser el cambio cuantitativo de los MT. Sin embargo, a pesar de esta lejana referencia, la historia de los MT arranca fundamentalmente en la segunda mitad del siglo XX; hay que tener en cuenta que diversas sustancias que posteriormente se utilizaron como MT han sido descubiertas hace relativamente poco tiempo: En la literatura se han publicado algunos estudios que evidencian que los MT se solicitan frecuentemente de forma inadecuada.

Antígeno carcinoembrionario

Es obvio que este MT ideal no existe por el momento. En el tercer grupo, esto es, el de los MT de baja especificidad se incluyen los MT con una sensibilidad dependiente del estadio, pero cuya especificidad es baja, incluso en las fases avanzadas de la enfermedad.

El hallazgo de concentraciones elevadas de cualquier marcador, de forma aislada, tiene un valor limitado. Si las cifras del marcador sufren un incremento continuo, se puede afirmar con bastante seguridad que el origen es tumoral. Se pueden realizar dos mediciones: Puede encontrarse en otras enfermedades malignas y benignas o incluso en pacientes sin enfermedad aparente.

Sin embargo, constituyen un reflejo de la actividad de la enfermedad y del crecimiento tumoral. Use of tumor markers in clinical practice: Marcadores tumorales en el tumor de primario desconocido. Medifam revista en la Internet. National Cancer Institute Consultado Antigeni Towards evidence-based use of serum tumor marker request: An audit of tumour marker requests in Northern Ireland.

  AW RP655 PDF

An audit of tumour marker utilization in Greece. Eur J Intern Med. Aspectos generales de los marcadores tumorales. Med Clin North Am. Review of commonly used serum tumor markers and their relevance for image interpretation. J Compot Assist Tomogr. The clinical carcinoembriobario of tumour markers in the management of ovarian cancer. Role of alpha-fetoprotein in the diagnosis and management of antigeni carcinoma. The Association of Biochemists in Ireland.

Guidelines for the use of tumour markers. Clinical application of tumour markers: East Afr Med J.

Antígeno carcinoembrionario | Cigna

Role of tumor markers in patients with solid tumors: Eur J Int Med. Sociedad Valenciana de Medicina Familiar y Comunitaria.

Consultado 02 Ene Form Med Contin Aten Prim.

Cancer and venous thromboembolism. The Trousseau Syndrome Revisited: Malignancies, prothrombotic mutations, and the risk of venous thrombosis.

Pruebas para detectar el cáncer de páncreas

Screening for occult cancer in patients with acute deep vein thrombosis or pulmonary embolism. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: Neoplasia oculta en pacientes con trombosis venosa carfinoembrionario esencial de las extremidades inferiores.

Recibido el 30 de diciembre de ABSTRACT Tumor markers are molecules usually glycoproteinsthe levels of which may be elevated in the presence of a cancer, either as a host’s reaction to the tumor or as a product of the tumor itself.

MT de muy elevada especificidad y sensibilidad. MT de especificidad y sensibilidad variable. MT de baja especificidad.

Posted in Art